Search Results
Jan 09, 2026, 08:02 ET iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference
II OCULE-01 study in uveal melanoma started in March 2025, the PULMO-01 study in non-small cell lung cancer (NSCLC) started in May 2025 and the HEMA-MED Phase I/II study in myelofibrosis began in November 2025.Logo :
More news about: iOnctura
Jan 08, 2026, 10:30 ET VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses
et al. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial. Nat Med 2023;29(8):2133-2141.
More news about: Astellas Pharma Inc.
Jan 08, 2026, 08:31 ET Arkstone Taps Ian Campbell as CEO to Lead Next Phase of Growth and Innovation
resistance and other major healthcare issues with precision-guided clinical decision support, after the company's recent early-stage funding from ARCHIMED's MED Rise fund. "Ian is a proven leader with a rare ability to scale technically complex platforms and successfully guide organizations through transformational
More news about: Arkstone
Jan 08, 2026, 03:00 ET Världskände tränaren Diego Simeone blir Betinias officiella ambassadör i historiskt samarbete
framsteg genom en utmaning i tränarstil som bygger på beslutsfattande, framsteg och belöningar, med ett spelupplägg designat för att återspegla den disciplin och strategi som Simeone är känd för."Med den upplevelse som Betinia skapat kommer fansen att kunna engagera sig direkt i spelets taktiska
More news about: Betinia
Jan 07, 2026, 08:50 ET ProRx Pharma Redefines NAD+ Delivery with New Oral System for Medical Clinics
committed to delivering safe, compliant, and high-quality compounded sterile and nonsterile preparations to physician practices, medical clinics, and med spas across the country. With a focus on preventative health, regulatory excellence, reliability, and customer service, ProRx partners with providers
More news about: ProRx Pharma
Jan 07, 2026, 08:34 ET The American Diabetes Association Welcomes 2026 Principal Officers and Members to the National Board of Directors
Neumiller, PharmD, CDCES, FADCES, FASCPChristopher Ralston, JDRobin RichardsonRhodes B. Ritenour, JDPatti Urbanski, MEd, RD, LD, CDCES, FADCES"Together, the members of this board bring tremendous expertise and dedication to the mission of the American Diabetes
More news about: American Diabetes Association
Jan 06, 2026, 17:35 ET NVIDIA CEO Jensen Huang tilldelas 2026 IEEE Medal of Honor, teknologins mest prestigefyllda erkännande
IEEE, världens största tekniska branschorganisation med fler än 500 000 medlemmar över hela världen, dedikerad till att främja teknik för mänskligheten, tillkännager stolt att Jensen Huang, grundare och vd
More news about: IEEE
Jan 06, 2026, 15:37 ET The Inner Circle acknowledges, Lori Lee Barr, MD, FACR, FAIUM as a 2026 Top Pinnacle Healthcare Professional
create more time freedom, influence, and profits so their joy returns. She is an encourager. Dr. Barr reminds her protegees that life is more than a med spa clinic, medical practice or dental practice. "The better doctors take care of themselves, the more likely their loved ones, practice partners, and
More news about: The Inner Circle
Jan 06, 2026, 09:05 ET VIO Med Spa Enters 2026 as the Category-Leading Med Spa Franchise, Positioned for Continued Expansion
row, VIO Med Spa has been recognized as one of the top franchises in Entrepreneur's Franchise 500®, the world's first, best, and most comprehensive franchise ranking. Of the more than 1,000 brands that were considered and 500 that were recognized, VIO Med Spa maintains its position as #1 in the med spa category
More news about: VIO Med Spa
Jan 06, 2026, 08:00 ET Cision avslöjar "Inside PR 2026": Den fullödiga rapporten om PR-trender, AI-anpassning och framtiden för kommunikation
tre chefer beskriver sin organisation som "extremt spänstig", håller endast 14 % av de anställda med. Strukturella hinder såsom teamstorlek och organisationsdesign (63 %) är tillsammans med långsamma godkännanden (53 %) de största faktorerna som håller team tillbaka.Sammantaget
More news about: Cision Ltd.
Jan 06, 2026, 08:00 ET Resonetics® Expands Bioelectronics Implant Offering with Acquisition of Manufacturing Assets and Process IP from Med-Ally
process know-how, and intellectual property related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally, a medical technology design and development company focused on the neuromodulation market and based in Charleston, South Carolina.
More news about: Resonetics, LLC
Jan 06, 2026, 08:00 ET Education Management Solutions Announces Nominees for 17th Annual Excellence in Clinical Simulation Awards
School of NursingKate Lindley, MSN, RN, CHSOS, CHSERasmussen UniversityMaria E. Vazquez-Amaral, JD, MEdRoseman University of Health Sciences College of MedicineThe winners of the 17th Annual Excellence in Clinical
More news about: Education Management Solutions (EMS)
Jan 05, 2026, 09:26 ET Hyphens Pharma vergibt Lizenz für Cerapro® MED Hautbarrierecreme für sechs europäische Länder
freut sich bekannt zu geben, dass er Louis Widmer SA („Louis Widmer") die Rechte zur Vermarktung seines innovativen Produkts Cerapro® MED Skin BarrierCream im Rahmen einer Lizenz-, Liefer- und Vermarktungsvereinbarung („Auslizenzierungsvereinbarung") für sechs europäische Länder,
More news about: Hyphens Pharma International Limited
Jan 05, 2026, 09:23 ET Hyphens Pharma obtient une licence dans six pays européens pour sa crème réparatrice et protectrice, Cerapro® MED
santé grand public de Singapour, a le plaisir d'annoncer qu'il a accordé les droits de commercialisation de son produit innovant, Cerapro® MED Skin Barrier Cream, à Louis Widmer SA (« Louis Widmer ») par le biais d'un accord de licence, de fourniture et de commercialisation (« Contrat
More news about: Hyphens Pharma International Limited
Jan 05, 2026, 09:03 ET Dr. Munique Maia Announces Harmony Surgery Center, a State-of-the-Art Surgical Center Opening in Tysons Corner in Early 2026
aesthetic approach.Located in Tysons Corner, Maia Plastic Surgery offers a full range of surgical and nonsurgical treatments, supported by Maia Med Spa and advanced aesthetic technologies.For more information or to view before-and-after results, visit
More news about: Maia Plastic Surgery
Jan 05, 2026, 08:00 ET Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
References: Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide 25 mg in adults with overweight or obesity. N Engl J Med. 2025; 393:1077-1087. DOI: 10.1056/NEJMoa2500969. Centers for Disease Control and Prevention. Adult obesity facts. Last accessed: December
More news about: NOVO NORDISK INC.
Jan 05, 2026, 05:36 ET Hyphens Pharma otorga licencias de Cerapro® MED Skin Barrier Cream a seis países europeos
especializados y atención médica al consumidor, se complace en anunciar la cesión de los derechos de comercialización de su innovador producto, Cerapro® MED Skin Barrier Cream, a Louis Widmer SA ("Louis Widmer") mediante un acuerdo de licencia, suministro y comercialización ("Acuerdo de Licencia")
More news about: Hyphens Pharma International Limited
Jan 05, 2026, 04:30 ET Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
pharmaceutical and consumer healthcare group, is pleased to announce that it has granted the rights to commercialise its innovative product, Cerapro® MED Skin Barrier Cream, to Louis Widmer SA ("Louis Widmer") via a licensing, supply and commercialisation agreement ("Out-Licensing Agreement")
More news about: Hyphens Pharma International Limited
Jan 05, 2026, 04:30 ET Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
pharmaceutical and consumer healthcare group, is pleased to announce that it has granted the rights to commercialise its innovative product, Cerapro® MED Skin Barrier Cream, to Louis Widmer SA ("Louis Widmer") via a licensing, supply and commercialisation agreement ("Out-Licensing Agreement")
More news about: Hyphens Pharma International Limited
Jan 01, 2026, 09:30 ET Shield of Odin Issues Educational Clarification on Independent Medical Documentation for Veterans
www.shieldofodin.com or call 1-855-VETS-MED.
More news about: Odin Industries LLC
Jan 01, 2026, 02:31 ET Shanghai Electric Tercantum dalam Jajaran Lima Besar dalam Peringkat Desalinasi Global
teknologi forward multi-effect distillation (F-MED) yang memakai waste heat industri.Proyek Desalinasi Hibrida Termal–Membran Yulong Petrochemical di Yantai, berkapasitas 160.000 ton per hari, menggunakan teknologi hibrida F-MED-RO yang mengintegrasikan proses termal dan membran.
More news about: Shanghai Electric
Dec 31, 2025, 10:13 ET Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares
character that Autoliv, Inc. is obliged to disclose in accordance with the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument). The information was distributed for disclosure, through the agency of the contact persons set out below, on December 31, 2025,
More news about: Autoliv
Dec 31, 2025, 10:10 ET Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares
character that Autoliv, Inc. is obliged to disclose in accordance with the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument). The information was distributed for disclosure, through the agency of the contact persons set out below, on December 31, 2025,
More news about: Autoliv
Dec 31, 2025, 09:14 ET Shanghai Electric、世界の海水淡水化ランキングでトップ5入り
Electricが中国国内で手掛けた最大の熱方式海水淡水化EPCプロジェクトであり、第1期および第2期を合わせて日量30万5,000トンの処理能力を有し、産業廃熱を動力源とする前進多重効用蒸留（F-MED）技術を採用しています。煙台におけるYulong Petrochemical熱・膜ハイブリッド海水淡水化プロジェクトは、日量16万トンの処理能力を有し、熱方式と膜方式を統合した新たなF-MED-ROハイブリッド技術を採用しています。低温産業廃熱を回収・活用する「カスケード利用」の手法を採用することで、グリーンかつ低炭素で、資源効率に優れた水生産を実現しています。同プロジェクトは、世界最大の熱・膜ハイブリッド型海水淡水化プロジェクトとして位置付けられています。今後もShanghai Electricは、包括的な技術ポ
More news about: Shanghai Electric
Dec 31, 2025, 05:57 ET Компания Shanghai Electric поднялась в топ-5 глобального рейтинга опреснителей воды
прямой многоколонной дистилляции (F-MED), работающей на промышленном отработанном тепле.Проект гибридной термально-мембранной дистилляции Yulong Petrochemical производительностью 160 000 тонн в день использует инновационную гибридную технологию F-MED-RO, в которой сочетаются термальные
More news about: Shanghai Electric